Ebola Viral Disease
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| A Study to Assess Safety, Tolerability, and Immunogenicity of Three Heterologus 2-dose Regimens of the Candidate Prophylactic Vaccines for Ebola in Healthy Adults (NCT02416453) | Janssen Vaccines & Prevention B.V. | 2015-06-15 |
Track Ebola Viral Disease automatically
Every clearance here is in the API, with alerts when new ones post.